Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 324 participants.
Also called NCT01056328
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 324 participants
- Sponsor
- Registry
-
NCT01056328
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01056328. Randomized; single masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2013-01 (actual). Results posted on 2014-05-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)
- Acronym
- IRASE-AF
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- SJM Irrigated Cardiac Ablation System
- Intervention (Device)
- FDA approved Open Irrigated RF Ablation System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01056328- Content hash
818d5cb6c88569d6f74eed52c9305ce0a4426f064069733cc89db534e8e40987